Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Menzel (Lund, Sweden), J. Nieto-Fontarigo (Lund, Sweden), M. Hvidtfeldt (Copenhagen, Denmark), S. Cerps (Lund, Sweden), S. Ramu (Lund, Sweden), A. Sverrild (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark), L. Uller (Lund, Sweden). Inflammatory phenotypes of asthma determine effect of inhaled corticosteroids on anti-viral immunity. 3697

Member's Comments

No comment yet.

Related content which might interest you: Impacts of inhaled corticosteroids on antiviral and antibacterial immunity in the lung Source: International Congress 2019 – Exploring the link between inhaled corticosteroids and respiratory infection Year: 2019 Advantageous toxicity profile of an inhaled GATA-3-specific DNAzyme intended for anti-inflammatory treatment of Th2-driven asthma Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD Year: 2012 Evaluation of the effect of inhaled ciclesonide on inflammatory and allergic markers and pulmonary function in bronchial asthma Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy Year: 2008 Interactions between antiviral and atopic inflammatory pathways sustain asthma exacerbations in children Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 Reducing the dose of inhaled corticosteroids (ICS) under therapy with montelukast in stable asthma: effects on lung function and inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 261s Year: 2001 Meta-analysis of inhaled corticosteroids response in children with asthma. Source: International Congress 2019 – Paediatric asthma: risk factors, biomarkers and the basics Year: 2019 Pharmacogenetics of inhaled corticosteroid response in adults with asthma Source: Virtual Congress 2020 – Asthma pharmacology: clinical trials and mechanistic insights Year: 2020 Effect of a novel inhaled glucocorticoid, ciclesonide, on an allergen-induced asthmatic response in rats and its prolonged anti-inflammatory activity in vitro Source: Eur Respir J 2002; 20: Suppl. 38, 91s Year: 2002 Protective effect of inhaled glucocorticosteroids on COPD model. Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Childhood asthma and responses to inhaled bronchodilating agents during early wheezing Source: Eur Respir J 2005; 26: Suppl. 49, 625s Year: 2005 Effects of inhaled corticosteroids on asthmatic inflammation: The FeNOtype trial Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Effects of treatment with N-acetylcysteine or inhaled corticosteroids on inflammatory mediators in COPD-patients Source: Eur Respir J 2003; 22: Suppl. 45, 5s Year: 2003 Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Mechanisms of systemic side effects of inhaled steroids Source: Eur Respir J 2004; 24: Suppl. 48, 347s Year: 2004 To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Source: Eur Respir J 2006; 27: 172-187 Year: 2006 The effect of inhaled and/or systemic corticosteroids on bone metabolism in asthmatic children Source: Annual Congress 2007 - Anti-inflammatory therapy for childhood asthma Year: 2007 Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness Source: Eur Respir J 2006; 27: 1144-1151 Year: 2006 Targeting small airways in asthma: the new challenge of inhaled corticosteroid treatment Source: Eur Respir J 2008; 31: 1145-1147 Year: 2008 Response of children with bronchial asthma to combined therapy with an oral immunostimulating drug and antileukotrienes Source: Eur Respir J 2005; 26: Suppl. 49, 159s Year: 2005